Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Scope of the Report:
The global average price of Bioresorbable Medical Material experienced a fluctuation trend, from 3100 USD/Kg in 2012 to 3128 USD/Kg in 2016. With the situation of global economy, prices will present a fluctuation trend in the following five years.
The classification of PLA, PGA, PCL, PLGA, Polysaccharides and others, and the proportion of PLA in 2016 is about 27%. And the proportion of PCL, PGA is about 19% and 16%, respectively.
Bioresorbable Medical Material is widely used for Orthopedics, Drug Delivery and others. The most proportion of Bioresorbable Medical Material is Orthopedics, and the proportion of Orthopedics in 2016 is 44%.
USA is the largest consumption place, with a consumption market share nearly 41% in 2016. Following USA, Europe is the second largest consumption place with the consumption market share of 32%.
Market competition is not intense. Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Bioresorbable Medical Material is expected to grow at a CAGR of roughly 9.2% over the next five years, will reach 1650 million US$ in 2024, from 970 million US$ in 2019, according to a new WMR study.
This report focuses on the Bioresorbable Medical Material in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bioresorbable Medical Material product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bioresorbable Medical Material, with price, sales, revenue and global market share of Bioresorbable Medical Material in 2017 and 2018.
Chapter 3, the Bioresorbable Medical Material competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioresorbable Medical Material breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Bioresorbable Medical Material market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Bioresorbable Medical Material sales channel, distributors, customers, research findings and conclusion, appendix and data source.